Page last updated: 2024-10-30

metformin and Neuralgia, Postherpetic

metformin has been researched along with Neuralgia, Postherpetic in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Neuralgia, Postherpetic: Pain in nerves, frequently involving facial SKIN, resulting from the activation the latent varicella-zoster virus (HERPESVIRUS 3, HUMAN). The two forms of the condition preceding the pain are HERPES ZOSTER OTICUS; and HERPES ZOSTER OPHTHALMICUS. Following the healing of the rashes and blisters, the pain sometimes persists.

Research Excerpts

ExcerptRelevanceReference
"Persons with type 2 diabetes (T2D) are prone to zoster infection and postherpetic neuralgia due to compromised immunity."5.91Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetes. ( Hsu, CC; Hwu, CM; Wei, JC; Yen, FS; Yip, HT, 2023)
"Persons with type 2 diabetes (T2D) are prone to zoster infection and postherpetic neuralgia due to compromised immunity."1.91Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetes. ( Hsu, CC; Hwu, CM; Wei, JC; Yen, FS; Yip, HT, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yen, FS1
Wei, JC1
Yip, HT1
Hsu, CC1
Hwu, CM1

Other Studies

1 other study available for metformin and Neuralgia, Postherpetic

ArticleYear
Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetes.
    Journal of medical virology, 2023, Volume: 95, Issue:1

    Topics: Cohort Studies; Diabetes Mellitus, Type 2; Herpes Zoster; Humans; Metformin; Neuralgia, Postherpetic

2023